Shopping Cart 0
Cart Subtotal
USD 0

Showing Repository 1-10 of 61 Reports

per page
Single User License Price
  1. Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry

    180 Pages| January 2019 |
    USD 4995
    The rheumatic disorder therapy area is multi-disciplinary in nature and encompasses conditions that affect joints, connective tissue, ligaments, tendons, cartilage, bone and muscle. Learn More
  2. Global Womens Health Drugs Market to 2024 - Influx of New Products Including Orilissa, Relugolix and Bremelanotide to Diversify Landscape and Drive Growth

    140 Pages| January 2019 |
    USD 4995
    The women's health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation. Learn More
  3. Gastrointestinal Diseases Drug Development Pipeline Review, 2018

    98 Pages| December 2018 |
    USD 3995
    This report provides an overview of the pipeline landscape for gastrointestinal diseases. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for gastroenteritis. Learn More
  4. Renal Diseases Drug Development Pipeline Review, 2018

    154 Pages| December 2018 |
    USD 3995
    This report provides an overview of the pipeline landscape for renal diseases. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for chronic kidney disease. Learn More
  5. Nonalcoholic Steatohepatitis Therapeutics in Asia-Pacific Markets to 2024 - Launch of NASH-Specific Premium Products and Rising Prevalence to Drive the Market

    112 Pages| December 2018 |
    USD 4995
    Non-alcoholic steatohepatitis (NASH) is the severe form of non-alcoholic fatty liver disease (NAFLD), characterized by a buildup of fat in the liver. Globally, the NAFLD prevalence rate is estimated to be around 25% and a significant proportion of th Learn More
  6. Atopic Dermatitis Therapeutics in Southeast Asia Markets to 2024 - Growth Driven by Rising Awareness and Expected Launch of Novel Therapies

    113 Pages| November 2018 |
    USD 4995
    Atopic dermatitis (AD), also called atopic eczema, is a chronic, pruritic, inflammatory skin disease arising from a complex interrelationship of environmental, immunologic, genetic, and pharmacologic factors, with a characteristic phenotype and typic Learn More
  7. Transplant Complications Drug Development Pipeline Review, 2018

    173 Pages| November 2018 |
    USD 3995
    This report provides an overview of the pipeline landscape for transplant complications. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for graft-versus-host disease (GV Learn More
  8. Chronic Respiratory Disease Drug Development Pipeline Review, 2018

    361 Pages| November 2018 |
    USD 3995
    This report provides an overview of the pipeline landscape for chronic respiratory diseases. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for asthma, chronic obstructi Learn More
  9. Epilepsy Therapeutics in Asia-Pacific Markets to 2024 - Uptake of Novel Therapies and Rising Awareness is Expected to Drive the Market Growth

    120 Pages| November 2018 |
    USD 4995
    Epilepsy is a chronic disorder of the brain with substantial morbidity. There are more than 65 million people with epilepsy globally, and this is growing because of the rapidly increasing population. Learn More
  10. Optic Nerve Disorders Drug Development Pipeline Review, 2018

    149 Pages| October 2018 |
    USD 3995
    This report provides an overview of the pipeline landscape for disorders of the optic nerve, the bundle of nerve fibers that transmits visual information from the eye to the brain. Learn More
Loading Indicator